BOOKS BY CATEGORY
Your Account
Evidence–Based Cardiology
This book is currently unavailable – please contact us for further information.
Price
Quantity
€219.60
(To see other currencies, click on price)
Other digital
Add to basket  

MORE ABOUT THIS BOOK

Main description:

Evidence based Cardiology was first published in 1998 to universal acclaim. It was praised as a unique cardiology text providing graded evidence–based reviews of the major trials together with recommendations for optimum management. Edited and written by the world′s leading cardiologists with an understanding of evidence–based medicine, it represented a breakthrough in clinical medical publishing, not only for cardiology.

With the move towards more patient focused health care and at the same time increased emphasis on health economics, evidence–based practice is a more important force in health care delivery than ever.


New features for the third edition
New chapters on:



  • Implementing evidence based cardiology

  • Cardiovascular disease and occupational health issues

  • Psychological factors

  • Social influences on the prevention of coronary heart disease

  • Molecular genetics of cardiovascular disorders

  • Integrated approach to prevention of cardiovascular disease including the global burden of disease; air pollution

  • Percutaneous intervention

  • Surgical coronary artery revascularization Comparisons of PCI and CABG

  • Unstable angina and non–ST–segment MI

  • Early management of ST–segment–elevation MI

  • Reperfusion therapies for STEMI

  • Reperfusion adjunctive therapies

  • Complications of STEMI

  • An integrated approach to the management of patients after the early phase of STEMI

  • Approaches to the repair/replacement of ischemic/infarcted myocardium

  • Atrial fibrillation: rate versus rhythm

  • Atrial fibrillation: Upstream therapies

  • Atrial fibrillation: ablation therapy

  • Biventricular pacing

  • New and old antiarrhythmic drugs

  • Arrhythmias due to monogenic disorders

  • New grading and recommendation methodology

  • Clinical cases redesigned and linked to the relevant chapters


Back cover:

Evidence based Cardiology was first published in 1998 to universal acclaim. It was praised as a unique cardiology text providing graded evidence–based reviews of the major trials together with recommendations for optimum management. Edited and written by the world′s leading cardiologists with an understanding of evidence–based medicine, it represented a breakthrough in clinical medical publishing, not only for cardiology.

With the move towards more patient focused health care and at the same time increased emphasis on health economics, evidence–based practice is a more important force in health care delivery than ever.


New features for the third edition
New chapters on:



  • Implementing evidence based cardiology

  • Cardiovascular disease and occupational health issues

  • Psychological factors

  • Social influences on the prevention of coronary heart disease

  • Molecular genetics of cardiovascular disorders

  • Integrated approach to prevention of cardiovascular disease including the global burden of disease; air pollution

  • Percutaneous intervention

  • Surgical coronary artery revascularization Comparisons of PCI and CABG

  • Unstable angina and non–ST–segment MI

  • Early management of ST–segment–elevation MI

  • Reperfusion therapies for STEMI

  • Reperfusion adjunctive therapies

  • Complications of STEMI

  • An integrated approach to the management of patients after the early phase of STEMI

  • Approaches to the repair/replacement of ischemic/infarcted myocardium

  • Atrial fibrillation: rate versus rhythm

  • Atrial fibrillation: Upstream therapies

  • Atrial fibrillation: ablation therapy

  • Biventricular pacing

  • New and old antiarrhythmic drugs

  • Arrhythmias due to monogenic disorders

  • New grading and recommendation methodology

  • Clinical cases redesigned and linked to the relevant chapters


Contents:

List of contributors, viii

Preface to the third edition, xiv


Classification of recommendations and levels of evidence, xvi


List of abbreviations, xvii


Part I: General concepts and critical appraisal
Salim Yusuf, Editor


1 Evidence–based decision making: patient physician interface, 3
Philip J Devereaux, Marc Pfeffer, Salim Yusuf


2 Obtaining incremental information from diagnostic tests, 14
Raymond J Gibbons


3 Clinical trials and meta–analysis, 26
Jonathan R Emberson, Colin Baigent


4 Understanding concepts related to health economics, 38
Mark A Hlatky


5 Major vascular complications in patients undergoing non–cardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention, 47
Philip J Devereaux, Matthew Chan, John Eikelboom


6 Implementing evidence–based medicine in cardiology, 63
Brahmajee K Nallamothu, Thomas T Tsai, Jack V Tu


7 The application of evidence–based medicine to employment fitness standards: the transportation industries with special reference to aviation, 79
Michael Joy


Part II: Prevention of cardiovascular diseases
Salim Yusuf and John A Cairns, Editors


8 Global perspective on cardiovascular disease, 95
K Srinath Reddy


9 Avoidance of worldwide vascular deaths and total deaths from smoking, 111
Prabhat Jha, Prem Mony, James Moore, Witold Zatonski


10 Tobacco and cardiovascular disease: achieving smoking cessation in cardiac patients, 125
Andrew Pipe


11 Lipids and cardiovascular disease, 138
Malcolm Law


12 Use of lipid–lowering agents in the prevention of cardiovascular disease, 147
R Alan Failor, Jeffrey L Probstfi eld


13 Blood pressure and cardiovascular disease, 165
Curt D Furberg, Bruce M Psaty, Elsayed Z Soliman


14 Dysglycemia and the risk of cardiovascular events, 179
Hertzel C Gerstein, Zubin Punthakee


15 Physical activity and exercise in cardiovascular disease prevention and rehabilitation, 190
Ray W Squires


16 Psychosocial factors, 201
Annika Rosengren


17 The social determinants of cardiovascular disease, 211
Martin McKee, Clara K Chow


18 Obesity, 221
Raj S Padwal, Arya M Sharma


19 Ethnicity and cardiovascular disease, 235
Clara K Chow, Sonia S Anand, Salim Yusuf


20 Fetal origins of coronary artery disease, 258
Katherine M Morrison, Stephanie Atkinson, Koon K Teo


21 Genetics of coronary heart disease, 268
Michael S Cunnington, Bernard D Keavney


22 Molecular genetics of cardiovascular disorders, 288
Ali J Marian, Robert Roberts


23 Diet and cardiovascular disease, 304
K Srinath Reddy


24 Integrating approaches to prevention of cardiovascular disease, 328
David A Wood, Kornelia Kotseva


Part IIIa: Stable coronary artery disease
John A Cairns and Bernard J Gersh, Editors


25 Medical management of stable coronary artery disease, 345
William E Boden


26 Percutaneous intervention, 357
David A Wood, Rohit Khurana, Christopher E Buller


27 Surgical coronary artery revascularization, 379
Morgan L Brown, Thoralf M Sundt III


28 Comparisons of percutaneous coronary intervention and coronary artery bypass grafting, 392
Arashk Motiei, Thoralf M Sundt III, Charanjit S Rihal


Part IIIb: Acute coronary syndromes
John A Cairns and Bernard J Gersh, Editors


29 Non–ST segment elevation acute coronary syndromes: unstable angina and non–ST segment elevation myocardial infarction, 409
Pierre Theroux, John A Cairns


30 Early prehospital management of ST segment elevation myocardial infarction, 444
Robert C Welsh, Paul W Armstrong


31 Reperfusion therapies for ST segment elevation myocardial infarction, 456
Joseph B Muhlestein, Jeffrey L Anderson


32 Antithrombotic therapies for patients with ST segment elevation myocardial infarction, 475
Andrew J Lucking, Keith A A Fox


33 Complications after myocardial infarction, 495
Peter L Thompson


34 An integrated approach to the management of patients after the early phase of ST segment elevation myocardial infarction, 516
Pedro L Sánchez, Francisco Fernández– Avilés


Part IIIc: Arrhythmias
A John Camm and John A Cairns, Editors


35 Atrial fibrillation: rhythm and rate control therapies, 531
Irina Savelieva, Albert L Waldo, A John Camm


36 Atrial fi brillation: upstream therapies, 568
Antonios Kourliouros, Irina Savelieva, Marjan Jahangiri, A John Camm


37 Atrial fibrillation: antithrombotic therapy, 581
John A Cairns, Stuart Connolly


38 Ablation therapy for atrial fi brillation, 596
Conor D Barrett, Chi Keong Ching, Luigi Di Biase, Claude S Elayi, David J Burkhardt, Rodney Horton, Andrea Natale


39 Supraventricular tachycardia, 606
Erica D Penny–Peterson, Gerald V Naccarelli


40 Prevention and treatment of life–threatening ventricular arrhythmia and sudden death, 619
Carlos A Morillo, Adrian Baranchuk


41 Pacemaker therapy, including cardiac resynchronization therapy, 636
William D Toff, A John Camm


42 Syncope, 673
David G Benditt, Fei Lu, Scott Sakaguchi


43 Cardiopulmonary resuscitation, 692
Michael Colquhoun


44 Arrhythmias due to monogenic disorders, 706
Dawood Darbar, Prince Kannankeril, Dan M L Roden


45 Arrhythmiagenic right ventricular cardiomyopathy, 721
Deirdre Ward, Perry M Elliott


Part IIId: Specifi c cardiovascular disorders: left ventricular dysfunction
Salim Yusuf, Editor


46 Epidemiology and prevention of heart failure and management of asymptomatic left ventricular systolic dysfunction, 735
J Paul Rocchiccioli, John J V McMurray


47 Management of overt heart failure, 756
Paul J Hauptman, Karl Swedberg


48 Acute myocarditis and dilated cardiomyopathy, 784
Leslie T Cooper Jr, Oyere K Onuma


49 Management of hypertrophic cardiomyopathy, 796
Barry J Maron


50 Infective and infi ltrative cardiomyopathies, 808
Stavros Kounas, Perry M Elliott


51 Chagas heart disease, 823
J Antonio Marin–Neto, Anis Rassi Jr, Benedito Carlos Maciel, Marcus Vinicius Simões, André Schmidt


Part IIIe: Specifi c cardiovascular disorders: pericardial disease
Bernard J Gersh, Editor


52 Pericardial disease: an evidence–based approach to clinical management, 845
Faisal F Syed, Bongani M Mayosi


Part IIIf: Specifi c cardiovascular disorders: valvular heart disease
Bernard J Gersh, Editor


53 Rheumatic heart disease: prevention and acute treatment, 861
Bongani M Mayosi, Patrick J Commerford


54 Mitral valve disease: indications for surgery, 869
Blase A Carabello


55 Surgical indications in aortic valve disease, 878
Sunil Mankad, Heidi M Connolly, Shahbudin H Rahimtoola


56 Non–surgical aortic valve therapy: balloon valvuloplasty and transcatheter aortic valve replacement, 896
Robert H Boone, John G Webb


57 Balloon valvuloplasty: mitral valve, 913
Zoltan G Turi


58 Valve repair and choice of valve, 927
Shafie S Fazel, Tirone E David


59 Infective endocarditis, 941
Zainab Samad, Andrew Wang


60 Antithrombotic therapy after heart valve replacement, 957
Jack C J Sun, John W Eikelboom


Part IIIg: Specifi c cardiovascular disorders: other conditions
Bernard J Gersh and Salim Yusuf, Editors


61 Stroke, 971
Brian H Buck, Ashfaq Shuaib, Craig Anderson


62 Heart disease and pregnancy, 993
Rachel M Wald, Samuel C Siu


63 Adult congenital heart disease, 1006
Elisabeth Bédard, Michael A Gatzoulis


64 Venous thromboembolic disease, 1032
Lori–Ann Linkins, Clive Kearon


65 Peripheral arterial disease, 1050
Catherine McGorrian, Sonia S Anand


66 Cardiac risk in those undergoing non–cardiac surgery, 1068
Ameeth Vedre, Kim A Eagle


67 Clinical management of diseases of the aorta, 1079
Thoralf M Sundt III


68 Cardiac transplantation: indications and postoperative management, 1099
Barry Boilson, Sudhir Kushwaha


69 Renal dysfunction, 1110
Johannes F E Mann, Ernesto L Schiffrin


70 Pulmonary hypertension, 1118
Brendan P Madden


Part IV: Clinical applications
Ernest L Fallen, Editor


71 Clinical applications of external evidence, 1135
Ernest L Fallen, Salim Yusuf


72 Stable angina: choice of PCI versus CABG versus drugs, 1138
William S Weintraub


73 Non–ST segment acute coronary syndrome, 1142
David Fitchett


74 Acute ST segment elevation myocardial infarction, 1152
Ernest L Fallen


75 Secondary prevention strategies post myocardial infarction, 1157
Jacques Genest


76 Heart failure, 1164
Michael M Givertz, Garrick C Stewart


77 Atrial fibrillation, 1170
Michael Klein


78 The case for and against implantable cardioverter defibrillators in patients with coronary artery disease, 1174
Jeffrey S Healey


79 Bradyarrhythmias choice of pacemakers, 1178
Pablo B Nery, Carlos A Morillo


80 Peripheral arterial disease with suspect coronary artery disease, 1183
Victor Aboyans, Michael H Criqui


81 Valvular heart disease: timing of surgery, 1187
Jon–David R Schwalm, Victor Chu


Index, 1191


The colour plate section can be found facing p. 941


PRODUCT DETAILS

ISBN-13: 9781444309768
Publisher: John Wiley & Sons Ltd (Wiley–Blackwell)
Publication date: May, 2010
Pages: 1240
Dimensions: 224.00 x 283.00 x 58.04
Weight: 3624g
Availability: Not available (reason unspecified)
Subcategories: Diseases and Disorders

MEET THE AUTHOR

Salim Yusuf, Professor of Medicine, Heart and Stroke Foundation Chair in Cardiology, and Director of the Population Health Research Institute, McMaster University, Hamilton, Ontario.


John Cairns Dean, Faculty of Medicine, University of British Columbia.


John Camm, Professor of Clinical Cardiology and Head of the Department of Cardiac & Vascular Sciences at St George′s, University of London.


Ernest Fallen, Professor Emeritus in Cardiology and Tutor in Cardiology Residency Program, McMaster University, Hamilton, Ontario.


Bernard Gersh, Professor of Medicine, Department of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Related books
From the same series

CUSTOMER REVIEWS

Average Rating